During the past decade, Kouseiren Takaoka Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kouseiren Takaoka Hospital" #1 sponsor was "Japan Clinical Cancer Research Organization" with 3 trials, followed by "Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan" with 2 trials sponsored, "Japan Multinational Trial Organization" with 1 trials sponsored, "National Hospital Organization Kinki-chuo Chest Medical Center" with 1 trials sponsored and "Taiho Pharmaceutical Co., Ltd." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kouseiren Takaoka Hospital" #1 collaborator was "Tokyo Medical and Dental University" with 2 trials as a collaborator, "Kitasato University" with 1 trials as a collaborator, "Korean Cancer Study Group" with 1 trials as a collaborator and "Taiho Pharmaceutical Co., Ltd." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Kouseiren Takaoka Hospital" are "Gastric Cancer" (4 trials), "Colorectal Cancer" (2 trials) and "Lung Cancer" (2 trials). Many other conditions were trialed in "Kouseiren Takaoka Hospital" in a lesser frequency.

Most popular intervention types in "Kouseiren Takaoka Hospital" are "Drug" (7 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "S-1" (2 trials), "UFT adjuvant chemotherapy" (2 trials), "ABI-007" (1 trials), "S-1 + irinotecan" (1 trials) and "carboplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kouseiren Takaoka Hospital" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Kouseiren Takaoka Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Kouseiren Takaoka Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kouseiren Takaoka Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".